Overall, Adropin inhibits adipogenesis as well as intracellular lipid accumulation, suggesting that it may improve diabetes by regulating lipid metabolism in adipose tissue as well as modulating the release of other adipokines. The gene discussed is ENHO; the disease is diabetes mellitus.